No Data
No Data
What Lies in Store for Healthcare ETFs in Q2 Earnings?
Amgen, Garmin Among Relative Market Leaders Poised to Outperform in Coming Months: BTIG
Investors in Amgen (NASDAQ:AMGN) Have Seen Splendid Returns of 122% Over the Past Five Years
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $360
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Beat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in Focus
No Data